Atlas Peak Capital
3
17M
3
0.23
2
- Stages of investment
- Areas of investment
Summary
Atlas Peak Capital is the famous VC, which was founded in 2011. The venture was found in North America in United States. The main office of represented VC is situated in the San Francisco.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Atlas Peak Capital, startups are often financed by Greenspring Associates, University Venture Fund, Sorenson Capital. The meaningful sponsors for the fund in investment in the same round are JMI Equity, Greenspring Associates. In the next rounds fund is usually obtained by SR One, Lundbeckfonden Ventures, Atlas Venture.
The fund was created by Brian DiLaura, Josh Blachman. We also calculated 2 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight Spero Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, SaaS.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2017.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.23
- Investments by industry
- Enterprise Software (2)
- Software (2)
- Marketing (1)
- SaaS (1)
- Information Technology (1) Show 8 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 500M
- Group Appearance index
- 1.00
- Avg. company exit year
- 19
- Avg. multiplicator
- 4.00
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Spero Therapeutics | 09 Apr 2014 | Biotechnology, Medical Device, Therapeutics | Early Stage Venture | 3M | United States, Cambridge, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.